Notice on Convening the 2024 Annual General Meeting
Filed with SSE · · 5 pages · Chinese
Lushang Freda Pharmaceutical Co., Ltd. on 6ix
Earlier from Lushang Freda Pharmaceutical
- Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Shandong Jurisdiction
- Report for Q1 2025
- Announcement on Convening the 2024 Annual Performance Briefing
- Announcement on Resolutions of the 4th Meeting of the 12th Board of Directors
- Announcement on "Corporate Value and Return Enhancement" Action Plan 2025
Later from Lushang Freda Pharmaceutical
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Notice on Convening the 1st Extraordinary General Meeting in 2025
- Announcement on Transfer of 100% Equity in Wholly-owned Subsidiary Shandong Lushang Inzone Commercial Management Co., Ltd. and Related Party Transaction
Follow Lushang Freda Pharmaceutical into a list and get an email when it puts out news.
Follow Lushang Freda Pharmaceutical